Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Polymeric nanoparticles and cancer: Lessons learnt from CRLX101
Ismael Gritli
, Edward Garmey
, Scott Eliasof
, Andres Tellez
, Mark E. Davis
,
Yen Yun
Taipei Municipal Wanfang Hospital
TMU Research Center of Cell Therapy and Regeneration Medicine
Ph.D. Program for Cancer Molecular Biology and Drug Discovery
Graduate Institute of Clinical Medicine
TMU Research Center of Cancer Translational Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
7
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Polymeric nanoparticles and cancer: Lessons learnt from CRLX101'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Malignant Neoplasm
100%
DNA Topoisomerase
60%
Clinical Trial
40%
Camptothecin
40%
Hypoxia Inducible Factor
40%
Neoplasm
40%
Antiangiogenic
20%
Antitumor Activity
20%
Cyclodextrin
20%
Hypoxia Inducible Factor 1
20%
Preclinical Study
20%
Enhanced Permeability and Retention Effect
20%